Understanding immune responses to develop vaccines and treatments for infectious diseases
NIH TETRAMER CORE FACILITY (HIV/AIDS)
This study is all about improving our knowledge of how our immune system fights infections like HIV/AIDS, and it helps researchers create better vaccines and treatments that could benefit patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11060157 on NIH RePORTER |
What this research studies
This research focuses on enhancing our understanding of immune responses to infectious diseases, particularly HIV/AIDS. It involves the NIH Major Histocompatibility Complex (MHC) Tetramer Core Facility, which synthesizes and distributes MHC tetramer reagents to researchers worldwide. By providing these essential tools, the facility aims to support the development of vaccines and novel therapies that can prevent and treat infectious diseases. Patients may benefit indirectly through advancements in treatment options that arise from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by HIV/AIDS and other infectious diseases.
Not a fit: Patients with non-infectious diseases or those not affected by HIV/AIDS may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and therapies for infectious diseases, enhancing patient care and outcomes.
How similar studies have performed: Previous research has shown success in using MHC tetramers to better understand immune responses, indicating that this approach is promising and has been validated in related studies.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.